Subscribe to our newsletter to receive the latest product updates and special offers

Order by Signal Tickers
Filters
Overview Valuation Financial Ownership Performance Technical ETF ETF Perf Custom Charts Tickers Basic TA News Snapshot Maps Stats
#1 / 19 Total
ADVM - Adverum Biotechnologies Inc - Stock Price Chart
TickerADVM [NASD]
CompanyAdverum Biotechnologies Inc
CountryUSA
IndustryBiotechnology
Market Cap366.67MEPS (ttm)-1.26
P/E-EPS this Y40.80%
Forward P/E-EPS next Y13.20%
PEG-EPS past 5Y-3.90%
P/S101.85EPS next 5Y-
P/B1.74EPS Q/Q19.29%
Dividend-Sales Q/Q-
Insider Own27.90%Inst Own33.33%
Insider Trans0.40%Inst Trans0.28%
Short Float3.63%EarningsMar 18/a
Analyst Recom1.33Target Price4.00
Avg Volume2.10M52W Range0.68 - 2.97
Adverum Biotechnologies, Inc. is a clinical-stage gene therapy company that engages in the development of gene therapies for ocular and rare diseases. The company was founded by Mark S. Blumenkranz, Thomas W. Chalberg, Jr., Mitchell H. Finer, and Steven Daniel Schwartz on July 17, 2006 and is headquartered in Redwood City, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Lupher, Jr. Mark L.DirectorFeb 07 '24Buy1.35130,000175,500130,000Feb 09 05:50 PM
Scopa James PaulDirectorFeb 07 '24Buy1.35100,000135,000100,000Feb 09 05:51 PM
Seyedkazemi SetarehChief Development OfficerSep 15 '23Sale1.526,2019,42947,674Sep 18 06:54 PM
Rubinstein Linda MChief Financial OfficerJun 07 '23Buy1.45100,000145,490100,000Jun 09 04:26 PM
ALPN - Alpine Immune Sciences Inc - Stock Price Chart
TickerALPN [NASD, RUT]
CompanyAlpine Immune Sciences Inc
CountryUSA
IndustryBiotechnology
Market Cap2.32BEPS (ttm)-0.64
P/E-EPS this Y-130.27%
Forward P/E-EPS next Y-17.64%
PEG-EPS past 5Y24.56%
P/S39.48EPS next 5Y-
P/B10.81EPS Q/Q135.59%
Dividend-Sales Q/Q1011.42%
Insider Own28.22%Inst Own68.33%
Insider Trans-16.25%Inst Trans37.62%
Short Float9.41%EarningsMar 18/a
Analyst Recom1.00Target Price37.00
Avg Volume1.06M52W Range6.39 - 39.27
Alpine Immune Sciences, Inc. is a development-stage pharmaceutical company, which engages in the discovery of protein-based immunotherapies to treat cancer and autoimmune and inflammatory diseases. Its product pipeline includes inflammatory diseases, immuno-oncology, and engineered cellular therapies. The company was founded in March 2007 and is headquartered in Seattle, WA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Rickey James PaulSee RemarksJan 26 '24Option Exercise8.30117,764977,84473,764Jan 29 07:04 PM
Rickey James PaulSee RemarksJan 26 '24Sale23.32117,7642,745,8300Jan 29 07:04 PM
Rickey James PaulSee RemarksJan 25 '24Option Exercise6.512361,536236Jan 29 07:04 PM
Rickey James PaulSee RemarksJan 25 '24Sale22.002365,1920Jan 29 07:04 PM
GOLD MITCHELLExecutive Chairman and CEODec 28 '23Option Exercise12.7474,441948,3782,675,421Dec 29 07:32 PM
AUGX - Augmedix Inc - Stock Price Chart
TickerAUGX [NASD]
CompanyAugmedix Inc
CountryUSA
IndustryHealth Information Services
Market Cap137.46MEPS (ttm)-0.44
P/E-EPS this Y5.30%
Forward P/E-EPS next Y54.40%
PEG-EPS past 5Y62.58%
P/S3.06EPS next 5Y-
P/B187.29EPS Q/Q38.77%
Dividend-Sales Q/Q44.90%
Insider Own10.86%Inst Own86.87%
Insider Trans50.79%Inst Trans0.70%
Short Float1.95%EarningsMar 18/a
Analyst Recom1.50Target Price6.00
Avg Volume363.70K52W Range1.34 - 6.25
Augmedix, Inc. engages in the development of software that converts natural clinician-patient conversations into medical documentation. It offers live support including referrals, orders, and reminders that allow clinicians to focus on patient care. The company was founded by Ian Shakil in 2012 and is headquartered in San Francisco, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Ginocchio PaulCHIEF FINANCIAL OFFICERNov 22 '23Buy4.8510,00048,500128,000Nov 27 07:00 AM
Redmile Group, LLCDirectorNov 20 '23Buy4.00750,0003,000,00016,404,017Nov 22 04:15 PM
Redmile Group, LLCDirectorNov 20 '23Buy4.00750,0003,000,0009,446,146Nov 22 04:15 PM
Traylor Margie L.DirectorJun 14 '23Buy4.5126,530119,64947,331Jun 16 05:50 PM
Traylor Margie L.DirectorMay 15 '23Option Exercise2.2010,18222,40020,801May 17 07:00 PM
BTBT - Bit Digital Inc - Stock Price Chart
TickerBTBT [NASD, RUT]
CompanyBit Digital Inc
CountryUSA
IndustryCapital Markets
Market Cap184.52MEPS (ttm)-0.99
P/E-EPS this Y-172.22%
Forward P/E-EPS next Y-96.15%
PEG-EPS past 5Y-83.26%
P/S5.39EPS next 5Y-
P/B2.23EPS Q/Q87.18%
Dividend-Sales Q/Q32.61%
Insider Own0.48%Inst Own43.88%
Insider Trans0.00%Inst Trans-44.94%
Short Float19.05%EarningsMar 18/a
Analyst Recom1.00Target Price6.07
Avg Volume9.71M52W Range1.12 - 5.27
Bit Digital, Inc. engages in the digital asset mining business and Ethereum staking activities. The company was founded in November 2015 and is headquartered in New York, NY.
CMTL - Comtech Telecommunications Corp. - Stock Price Chart
TickerCMTL [NASD, RUT]
CompanyComtech Telecommunications Corp.
CountryUSA
IndustryCommunication Equipment
Market Cap130.96MEPS (ttm)-0.87
P/E-EPS this Y80.17%
Forward P/E15.08EPS next Y227.08%
PEG-EPS past 5Y-
P/S0.23EPS next 5Y17.00%
P/B0.30EPS Q/Q75.36%
Dividend-Sales Q/Q15.84%
Insider Own7.05%Inst Own70.27%
Insider Trans0.00%Inst Trans-1.89%
Short Float3.91%EarningsMar 18/a
Analyst Recom2.00Target Price17.08
Avg Volume364.14K52W Range4.13 - 13.17
Comtech Telecommunications Corp. engages in the provision of emergency systems and wireless and satellite communications. It operates through Satellite and Space Communications and Terrestrial and Wireless Networks segments. The Satellite and Space Communication segment offers satellite ground station technologies, services and system integration that facilitate the transmission of voice, video, and data over GEO, MEO, and LEO satellite constellations, including solid-state and traveling wave tube power amplifiers, modems, VSAT platforms and frequency converters. The Terrestrial and Wireless Networks segment provides SMS Text to 911 services, providing alternate paths for individuals who need to request assistance method to reach Public Safety Answering Points. The company was founded in 1967 and is headquartered in Melville, NY.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Carpenter Wendi B.DirectorJun 26 '23Buy9.601,0009,6004,506Jun 28 09:02 PM
Quinlan Mark R.DirectorJun 21 '23Buy8.89100,000888,570347,639Jun 23 04:55 PM
Carpenter Wendi B.DirectorJun 15 '23Buy9.201,0009,2003,500Jun 15 06:04 PM
HEDDEN MARIAChief Operating OfficerJun 14 '23Buy8.952,23319,9857,247Jun 15 04:06 PM
Walther Donald E.Chief Legal OfficerJun 14 '23Buy8.865004,4301,000Jun 14 04:10 PM
DLO - DLocal Limited - Stock Price Chart
TickerDLO [NASD]
CompanyDLocal Limited
CountryUSA
IndustrySoftware - Infrastructure
Market Cap5.38BEPS (ttm)0.48
P/E37.89EPS this Y53.35%
Forward P/E17.62EPS next Y37.31%
PEG1.16EPS past 5Y-
P/S9.27EPS next 5Y32.70%
P/B12.22EPS Q/Q39.20%
Dividend-Sales Q/Q46.54%
Insider Own74.79%Inst Own20.51%
Insider Trans0.00%Inst Trans0.10%
Short Float7.88%EarningsMar 18/a
Analyst Recom2.60Target Price19.75
Avg Volume894.00K52W Range9.04 - 24.22
DLocal Ltd. engages in the business of simplifying and redefining online payments experience. It focuses on processing payment transactions which enables merchants to get paid from customers and to make payments to customers in emerging markets. The company was founded by Andres Bzurovski Bay and Sergio Enrique Fogel Kaplan in 2016 and is headquartered in Montevideo, Uruguay.
EYEN - Eyenovia Inc - Stock Price Chart
TickerEYEN [NASD, RUT]
CompanyEyenovia Inc
CountryUSA
IndustryBiotechnology
Market Cap67.50MEPS (ttm)-0.67
P/E-EPS this Y-38.31%
Forward P/E-EPS next Y-14.72%
PEG-EPS past 5Y-7.37%
P/S-EPS next 5Y-
P/B4.16EPS Q/Q13.36%
Dividend-Sales Q/Q-
Insider Own18.44%Inst Own25.89%
Insider Trans0.28%Inst Trans-31.84%
Short Float8.03%EarningsMar 18/a
Analyst Recom1.00Target Price9.25
Avg Volume738.68K52W Range1.05 - 5.85
Eyenovia, Inc. is a clinical stage biopharmaceutical company, which engages in the research and development of ophthalmology products. The company offers a piezo-print technology to deliver micro-doses of micro-therapeutics for the eyes. Its products include MicroProst, MicroStat, MicroTears, and MicroPine. The firm is currently focused on the late-stage development of microdosed medications for presbyopia, myopia progression, and mydriasis. The company was founded by Sean Ianchulev on March 12, 2014 and is headquartered in New York, NY.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Grant Stuart M.10% OwnerMar 08 '24Buy1.5810,71716,9115,280,715Mar 11 08:11 AM
Rowe Michael MChief Executive OfficerDec 04 '23Buy1.364,8906,65032,927Dec 05 04:54 PM
Strahlman Ellen RDirectorSep 29 '23Buy1.684,8208,09875,113Oct 02 10:04 AM
Rowe Michael MChief Executive OfficerSep 19 '23Buy1.661,4002,32428,037Sep 19 05:17 PM
Rowe Michael MChief Executive OfficerSep 15 '23Buy1.751,1371,99026,637Sep 19 05:17 PM
FINV - FinVolution Group ADR - Stock Price Chart
TickerFINV [NYSE]
CompanyFinVolution Group ADR
CountryChina
IndustryCredit Services
Market Cap842.31MEPS (ttm)1.18
P/E4.23EPS this Y20.83%
Forward P/E2.90EPS next Y22.44%
PEG2.42EPS past 5Y-
P/S0.48EPS next 5Y1.75%
P/B0.46EPS Q/Q-7.83%
Dividend4.75%Sales Q/Q1.76%
Insider Own0.03%Inst Own50.91%
Insider Trans0.00%Inst Trans-0.25%
Short Float0.87%EarningsMar 18/a
Analyst Recom1.00Target Price6.31
Avg Volume800.68K52W Range3.55 - 6.05
FinVolution Group is an online consumer finance platform in China connecting underserved individual borrowers with financial institutions. It developed technologies and accumulated in-depth experience in the core areas of credit risk assessment, fraud detection, big data, and artificial intelligence. The company's platform empowered by proprietary cutting-edge technologies, features an automated loan transaction process, which enables superior user experience. The company was founded by Shao Feng Gu, Hong Hui Hu, Tie Zeng Li, and Jun Zhang in June 2007 and is headquartered in Shanghai, China.
LTRN - Lantern Pharma Inc - Stock Price Chart
TickerLTRN [NASD]
CompanyLantern Pharma Inc
CountryUSA
IndustryBiotechnology
Market Cap108.27MEPS (ttm)-1.40
P/E-EPS this Y-33.56%
Forward P/E-EPS next Y27.16%
PEG-EPS past 5Y-47.77%
P/S-EPS next 5Y-
P/B2.38EPS Q/Q-39.40%
Dividend-Sales Q/Q-
Insider Own26.51%Inst Own10.80%
Insider Trans-19.46%Inst Trans0.91%
Short Float0.85%EarningsMar 18/a
Analyst Recom1.00Target Price20.50
Avg Volume206.41K52W Range2.38 - 9.59
Lantern Pharma, Inc. engages in the development of drugs through leveraging artificial intelligence, machine learning, and genomic data. Its portfolio includes LP-100, LP-300, and LP-184. The company was founded by Arun K. Asaithambi, Gregory T. Tobin, and Peter L. Nara on November 7, 2013 and is headquartered in Dallas, TX.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Kreis Leslie W.10% OwnerFeb 29 '24Sale4.8719,70395,95460,256Feb 29 09:54 PM
Fletcher Aaron G.L.10% OwnerFeb 29 '24Sale4.8719,70395,95460,256Feb 29 09:54 PM
Fletcher Aaron G.L.10% OwnerFeb 28 '24Sale4.8574,297360,34062,088Feb 29 09:54 PM
Kreis Leslie W.10% OwnerFeb 28 '24Sale4.8574,297360,34062,088Feb 29 09:54 PM
Kreis Leslie W.10% OwnerFeb 27 '24Sale4.4050,000220,00068,997Feb 29 09:54 PM
MITK - Mitek Systems Inc - Stock Price Chart
TickerMITK [NASD, RUT]
CompanyMitek Systems Inc
CountryUSA
IndustrySoftware - Application
Market Cap556.20MEPS (ttm)0.17
P/E72.92EPS this Y14.15%
Forward P/E10.09EPS next Y12.66%
PEG4.86EPS past 5Y-
P/S3.24EPS next 5Y15.00%
P/B2.67EPS Q/Q-471.43%
Dividend-Sales Q/Q-4.54%
Insider Own3.24%Inst Own78.13%
Insider Trans-5.66%Inst Trans0.19%
Short Float6.95%EarningsMar 19/a
Analyst Recom1.00Target Price17.50
Avg Volume355.71K52W Range8.73 - 13.98
Mitek Systems, Inc. engages in the development of mobile capture and digital identity verification solutions. The company was founded in 1986 and is headquartered in San Diego, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
CARNECCHIA SCIPIO MAXIMUSChief Executive OfficerDec 07 '23Sale10.8656,113609,387500,795Dec 12 01:58 PM
Diamond Michael EGeneral ManagerDec 07 '23Sale10.867,24278,648266,304Dec 12 01:56 PM
Briggs Christopher HSVP IdentityDec 07 '23Sale10.862,28724,83792,673Dec 12 01:51 PM
CARNECCHIA SCIPIO MAXIMUSChief Executive OfficerDec 01 '23Sale11.0712,370136,936556,908Dec 12 01:58 PM
Diamond Michael EGeneral ManagerDec 01 '23Sale11.071,99622,096273,546Dec 12 01:56 PM
12